Development and validation of a rapid HPLC method for the determination of oseltamivir phosphate in Tamiflu® and generic versions

Journal of Pharmaceutical and Biomedical Analysis

Volumn 44, Issue 4, 2007, Pages 1008-1013

  Joseph Charles, J ^a   Geneste, C ^a   Laborde Kummer, E ^a   Gheyouche, R ^b   Boudis, H ^b   Dubost, J P ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b Université Benyoucef Ben Khedda   (Algeria)

Author keywords

Bird flu; Counterfeit; Generic versions; Oseltamivir phosphate; RPLC UV; Tamiflu

Indexed keywords

FORMIC ACID; GENERIC DRUG; METHANOL; OSELTAMIVIR; SOTALOL;

ACCURACY; ARTICLE; AVIAN INFLUENZA; DRUG CAPSULE; DRUG DETERMINATION; DRUG MARKETING; DRUG MONITORING; DRUG QUALITY; DRUG RETENTION; ENVIRONMENTAL TEMPERATURE; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PH; PRIORITY JOURNAL; QUALITY CONTROL; REVERSED PHASE LIQUID CHROMATOGRAPHY; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

ANTIVIRAL AGENTS; CAPSULES; CENTRIFUGATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUGS, GENERIC; HYDROGEN-ION CONCENTRATION; OSELTAMIVIR; POWDERS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS;

EID: 34447623918     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.04.002     Document Type: Article

References (15)

1. McClellan K., and Perry C.M. Drugs 61 (2001) 263-283
2. Dreitlein W.B., Maratos J., and Brocavich J. Clin. Ther. 23 (2004) 327-355
3. Hayden F.G., Atmar R.L., Schilling M., Johnson C., Poretz D., Paar D., Huson L., Ward P., and Mills R.G. N. Engl. J. Med. 341 (1999) 1336-1343
4. Nicholson K.G., Aoki F.Y., Osterhaus A.D.M.E., Trottier S., Carewicz O., Mercier C.H., Rode A., Kinnersley N., and Ward P. Lancet 355 (2000) 1845-1850
5. Enserink M. Science 312 (2006) 382-383
6. Abbott A., and Pearson H. Nature 427 (2004) 472-473
7. Oxford J. Expert Opin. Pharmacother. 6 (2005) 2493-2500
8. World Health Organization, WHO Media Centre, Counterfeit medicines, Fact sheet No. 275, Revised February 2006, Available from http://www.who.int/mediacentre/factsheets/fs275/en/
9. Li W., Escarpe P.A., Eisenberg E.J., Cundy K.C., Sweet C., Jakeman K.J., Merson J., Lew W., Williams M., Zhang L., Kim C.U., Bischofberger N., Chen M.S., and Mendel D.B. Antimicrob. Agents Chemother. 42 (1998) 647-653
10. Eisenberg E.J., and Cundy K.C. J Chromatogr. B 716 (1998) 267-273
11. Wiltshire H., Wiltshire B., Citron A., Clarke T., Serpe C., Gray D., and Herron W. J. Chromatogr. B 745 (2000) 373-388
12. Lindegardh N., Hien T.T., Farrar J., Singhasivanon P., White N.J., and Day N.P.J. J. Pharm. Biomed. Anal. 42 (2006) 430-433
13. International Conference on Harmonisation, ICH Guidelines Q2(R1): Validation of Analytical Procedures, Text and Methodology Ref CPMP/ICH/381/95, Available from URL: http://www.ich.org/cache/compo/276-254-1.html
14. Product Monograph, Tamiflu, Hoffmann-La Roche Limited, Revised August 31, 2006, Missianga, Ontario, Canada, Available from: URL: http://www.rochecanada.com/pdf/tamifluSIE.pdf.
15. Foster R.T., and Carr R.A. Sotalol. In: Brittain H.G., and Florey K. (Eds). Analytical Profiles of Drug Substances and Excipients 21 (1992), Academic Press, Inc., San Diego 501-533